Last Price$57.72.0%
Market Cap$143.6B
7.0%
Peers median - 0.9%
13.1%
Peers median - 11.1%
142.1%
Peers median - 78.8%
31.3%
Peers median - 17.2%
Competing with UL
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$143.6B | 7.0 | $90.7 57.2% undervalued | 20.3% | €120.4B | €15.8B | 7.0% | 13.1% | 71.4% | 31.3% | 142.1% | |
$411.8B | 7.1 | $135.9 22.6% overvalued | 12.1% | $84.3B | $16.7B | 0.5% | 19.8% | 51.3% | 19.2% | 67.4% | |
$75.3B | 7.0 | $83.3 10.2% overvalued | 8.6% | $20.1B | $3,546.0M | 3.3% | 17.6% | 60.5% | 30.9% | 1,564.7% | |
$47.9B | 6.4 | $160.0 11.6% undervalued | 20.3% | $20.1B | $2,513.0M | (1.8%) | 12.5% | 35.8% | 28.9% | 705.1% | |
$45.5B | 5.8 | $21.1 11.3% overvalued | 29.2% | $15.5B | $1,335.0M | 0.1% | 8.6% | 57.9% | 10.1% | 90.2% | |
$27.1B | 6.3 | $79.8 28.8% overvalued | 11.9% | $6,107.1M | $976.4M | 4.1% | 16.0% | 45.2% | 8.9% | 41.1% | |
$25.7B | 5.0 | $93.6 33.4% undervalued | (51.7%) | $15.2B | $1,145.0M | 0.1% | 7.6% | 73.1% | 0.2% | 225.1% | |
$19.3B | 6.6 | $117.2 24.8% overvalued | 5.0% | $7,165.0M | $695.0M | (2.0%) | 9.7% | 44.5% | 38.2% | 2,555.4% | |
$9,261.6M | 7.3 | $22.2 45.4% overvalued | 176.7% | $1,476.5M | $198.3M | 69.3% | 13.4% | 76.6% | 55.5% | 2.4% | |
$4,901.6M | 5.1 | $15.4 182.3% undervalued | (56.1%) | $6,090.4M | $293.5M | 1.3% | 4.8% | 64.6% | 7.0% | 7.8% | |
$3,814.9M | 6.1 | $64.1 0.4% undervalued | (69.5%) | $1,302.0M | $24.6M | 46.3% | 1.9% | 71.1% | 15.2% | 39.4% |
Compare UL Valuation Multiples with Peers
LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
General
Valuation Multiple
Financial metrics
Company name
EV/Revenue
Revenue growth
EBITDA margin
Net Income margin
Unilever PLCUL
1.3x
1.8%
(12.4%)
10.9%
Median Peer Set
3.3x
2.9%
(9.4%)
8.1%
Church & Dwight Co., Inc.CHD
4.6x
4.1%
(22.7%)
9.6%
Colgate-Palmolive CompanyCL
4.1x
3.3%
27.0%
14.4%
The Clorox CompanyCLX
3.1x
(4.0%)
86.0%
3.9%
Coty Inc.COTY
0.8x
10.2%
(85.0%)
1.5%
The Estée Lauder Companies Inc.EL
2.1x
(1.9%)
(61.2%)
2.5%
e.l.f. Beauty, Inc.ELF
3.1x
76.9%
99.1%
12.5%
Hims & Hers Health, Inc.HIMS
6.1x
65.5%
(65.6%)
(2.7%)
Kimberly-Clark CorporationKMB
2.7x
(1.8%)
45.5%
12.7%
Kenvue Inc.KVUE
3.4x
0.1%
(40.0%)
6.7%
The Procter & Gamble CompanyPG
5.2x
2.5%
3.8%
17.7%
Compare UL Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does Unilever PLC (UL) revenue growth compare to peers and the industry?
Unilever PLC (UL) revenue growth is 7.0%, compared to the peers' median of 0.9%.
2. How does Unilever PLC (UL) Free Cash Flow (FCF) margin compare to peers and the industry?
Unilever PLC (UL) FCF margin is 13.1%, compared to the peers' median of 11.1%.
3. How does Unilever PLC (UL) Total Debt to Equity ratio compare to peers and the industry?
Unilever PLC (UL) Total Debt to Equity ratio is 142.1%, compared to the peers' median of 78.8%.
4. How does Unilever PLC (UL) ROIC (Return on Invested Capital) compare to peers and the industry?
Unilever PLC (UL) ROIC is 31.3%, compared to the peers' median of 17.2%.